Monte Rosa Therapeutics (GLUE) Revenue (2020 - 2026)
Monte Rosa Therapeutics (GLUE) revenue from Mar 31, 2020 to Mar 31, 2026. The TTM Monte Rosa Therapeutics (GLUE) revenue is $40M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Monte Rosa Therapeutics (GLUE) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -74.82% |
Annual Revenue change of Monte Rosa Therapeutics (GLUE)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $4.21M | -96.60% |
| 2025 | $124M | +63.54% |
| 2024 | $76M | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |